Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.
J Nucl Med
; 63(6): 882-889, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-34503962
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Embolization, Therapeutic
/
Chemical and Drug Induced Liver Injury
/
Liver Neoplasms
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article